Bio Pharma Dive
JULY 22, 2024
The company plans to start a late-stage study next year, after a smaller trial found its drug offered “robust and consistent” benefits on communication, cognition and motor function.
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JULY 22, 2024
Serum-based glycoproteins demonstrate success in predicting immune checkpoint inhibitor therapy outcomes.
Rethinking Clinical Trials
JULY 22, 2024
July 15-16, 2024 : The NIH Pragmatic Trials Collaboratory hosted a Workshop at the 2023 AcademyHealth 16th Annual Conference on the Science of Dissemination and Implementation in Health. This training workshop introduces concepts in the design, conduct, and implementation of embedded pragmatic clinical trials (ePCTs), and provides firsthand ePCT experiences and case studies from the NIH Pragmatic Trials Collaboratory Trials.
Bio Pharma Dive
JULY 22, 2024
The Health and Human Services' inspector general issued a "negative opinion" on Bluebird's request one week after Vertex sued the federal government over access to fertility preservation services.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 22, 2024
Scientists have figured out a non-invasive way to determine if a transplanted organ is failing to take in a patient – no matter if it’s a kidney, liver, lung, or heart.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JULY 22, 2024
As VP Kamala Harris enters the presidential race, her strong stances for reproductive rights and drug access offer insights into future actions.
Bio Pharma Dive
JULY 22, 2024
Clinical data registries have become invaluable for generating unique insights for life sciences. Read on to learn more.
Pharmaceutical Technology
JULY 22, 2024
The UK NICE has recommended Accord's Relugolix as a treatment for advanced hormone-sensitive prostate cancer in its final draft guidance.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 22, 2024
Exports of drugs and pharmaceuticals from the country registered a 9.3 per cent growth in the first three months of the fiscal year from April to June, 2024, while imports reported a jump of 12.4 per cent, compared to the corresponding quarter of previous year. The exports during the three months stood at $7.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
Bio Pharma Dive
JULY 22, 2024
The company is seeking a monotherapy approval for Spravato, sales of which have climbed in recent quarters.
Pharmaceutical Technology
JULY 22, 2024
Astellas Pharma subsidiaries and Osaka University in Japan link to develop pluripotent stem cell-derived cartilage organoid cell therapy.
Fierce Pharma
JULY 22, 2024
After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. | Agilent has revealed that it’s signed a definitive agreement to acquire Biovectra for $925 million through a mix of cash and debt financing. The deal is expected to close this year.
Pharmaceutical Technology
JULY 22, 2024
Understanding of cell therapies is rapidly improving, but there remain significant challenges in getting new therapies onto the market.
pharmaphorum
JULY 22, 2024
Consumer wearables have shown a benefit when used to monitor treatment responses in patients with atrial fibrillation and heart failure.
Pharmaceutical Technology
JULY 22, 2024
GRO Biosciences has secured $60.3m in a Series B financing round to progress the clinical development of its lead programme for gout.
pharmaphorum
JULY 22, 2024
Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and Eli Lilly.Mazdutide – a once-weekly injectable Innovent licensed from Lilly – was submitted to China's National Medical Products Administration (NMPA) earlier this year for weight management in overweight and obesity, and will soon be submitted for type 2 diabetes as well after a second positive phase 3 trial,
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
JULY 22, 2024
The UK MHRA has granted approval for the use of Lupin Healthcare and Zentiva Pharma’s generic raltegravir medicines for treating HIV.
Pharma Times
JULY 22, 2024
Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK
Pharmaceutical Technology
JULY 22, 2024
The EMA has accepted for review GSK’s MAA for Blenrep for relapsed or refractory multiple myeloma (r/r MM).
pharmaphorum
JULY 22, 2024
Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life-threatening mosquito-borne disease.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JULY 22, 2024
The SOD2 mRNA delivered with SemaPhore technology showed improved survival rates for mice with abdominal aortic aneurysm.
Fierce Pharma
JULY 22, 2024
As lawmakers and industry groups seek to get a handle on U.S. | As lawmakers and industry groups seek to get a handle on U.S. drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat.
Pharmaceutical Technology
JULY 22, 2024
The company’s Tpoxx vaccine is used to treat orthopoxvirus but is only approved for treating smallpox by the US FDA.
Fierce Pharma
JULY 22, 2024
The door is closing on bluebird bio’s attempt to secure Medicaid coverage for its fertility support program, which is already offered to patients with commercial insurance who receive its gene ther | The door is closing on bluebird bio’s attempt to secure Medicaid coverage for its fertility support program, which is already offered to patients with commercial insurance who receive its gene therapies.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
JULY 22, 2024
UNAIDS executive director Winnie Byanyima called upon Gilead to allow generics to be made of lenacapavir now.
Fierce Pharma
JULY 22, 2024
At his vacation home in Delaware, President Joe Biden made the striking announcement that he is dropping out of the 2024 | While President Joe Biden is officially out for the 2024 election, his term has certainly made a mark in the healthcare realm.
Pharmaceutical Technology
JULY 22, 2024
UNAIDS executive director Winnie Byanyima called upon Gilead to allow generics to be made of Sunlenca now.
Outsourcing Pharma
JULY 22, 2024
Apollo Therapeutics and the University of Oxford have embarked on a collaborative journey in drug discovery and development.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
282 
Let's personalize your content